Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rigel Pharmaceuticals

21.91
+0.85004.04%
Post-market: 21.910.00000.00%18:22 EDT
Volume:179.26K
Turnover:3.87M
Market Cap:391.58M
PE:10.52
High:22.03
Open:20.65
Low:20.28
Close:21.06
Loading ...

Rigel Pharmaceuticals reports Q4 EPS 80c, consensus 58c

TIPRANKS
·
05 Mar

Rigel Pharmaceuticals sees FY25 revenue $200M-$210M, consensus $204.88M

TIPRANKS
·
05 Mar

Rigel Pharmaceuticals Q4 EPS $0.80 Beats $0.47 Estimate, Sales $57.60M Beat $51.73M Estimate

Benzinga
·
05 Mar

BRIEF-Rigel Pharmaceuticals Q4 EPS USD 0.81 Vs. IBES Estimate USD 0.47

Reuters
·
05 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Mar

Rigel Pharmaceuticals Inc expected to post earnings of 47 cents a share - Earnings Preview

Reuters
·
01 Mar

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks
·
01 Mar

Sea Limited to Post Q4 Earnings: What's in Store for the Stock?

Zacks
·
01 Mar

High Growth Tech Stocks In The US Market To Watch

Simply Wall St.
·
28 Feb

Should You Add RIGL Stock to Your Portfolio Pre-Q4 Earnings?

Zacks
·
26 Feb

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

PR Newswire
·
25 Feb

RIGL Stock Surges 41.4% in a Year: Time to Buy or Sell?

Zacks
·
24 Feb

4 Healthcare Stocks to Buy as the Sector Stages a Comeback

Zacks
·
24 Feb

U.S. RESEARCH ROUNDUP-Amneal pharma, Aramark, Bluebird Bio

Reuters
·
24 Feb

With 57% ownership of the shares, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is heavily dominated by institutional owners

Simply Wall St.
·
23 Feb

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Held Back By Insufficient Growth Even After Shares Climb 38%

Simply Wall St.
·
06 Feb

Does Rigel (RIGL) Have the Potential to Rally 40.88% as Wall Street Analysts Expect?

Zacks
·
03 Feb